Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03876444

Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms (MPIV)

Intravenous Methylprednisolone Versus High Dose Oral Prednisolone for the Treatment of Infantile Spasms: a Randomized Open-labelled Trial

Sponsor: Suvasini Sharma

Conditions Infantile Spasm

Interventions Intravenous Methylprednisolone Oral Pednisolone

Updated 6 times since 2019 Last updated: Nov 14, 2019 Started: Apr 1, 2019 Primary completion: Apr 30, 2022 Completion: Oct 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Infantile Spasm and is currently ongoing. Suvasini Sharma leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Recruiting PHASE2_PHASE3
Dec 2019 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2019 — Dec 2019 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Suvasini Sharma

Data source: Lady Hardinge Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India